Galectin Therapeutics Inc (GALT) - News Archive

Showing 2 of 2 results.

In an era marked by rapid advancements in biotechnology, Galectin Therapeutics, Inc. (NASDAQ GALT) stands a...

Navigating New Frontiers: Galectin Therapeutics Shares Promising Results from NAVIGATE Trial Amid Industry Challenges In an era marked by rapid advancements in biotechnology, Galectin Therapeutics, Inc. (NASDAQ: GALT) s...

Dec 20, 2024 • Major Pharmaceutical Preparations Industry Clinical Study Get Free Report Galectin Therapeutics Friday Get F

Galectin Therapeutics to Present Three Key s at AASLD 2024 on Innovative Treatments for MASH Cirrhosis ...

On October 15, 2024, Galectin Therapeutics Inc. (NASDAQ: GALT), a pioneering biopharmaceutical company focused on developing innovative therapies that target galectin proteins, made an exciting announcement regarding th...

Oct 15, 2024 • Major Pharmaceutical Preparations Industry Clinical Study